首页> 外文期刊>International Journal of Pharmaceutics >Comparison of commercial serum-free media for CHO-K1 cell growth and monoclonal antibody production
【24h】

Comparison of commercial serum-free media for CHO-K1 cell growth and monoclonal antibody production

机译:用于CHO-K1细胞生长和单克隆抗体生产的商业无血清培养基的比较

获取原文
获取原文并翻译 | 示例
       

摘要

The selection of a serum-free medium for a particular process of production using mammalian cells is a critical step for its success. In this study, seven commercially available serum-free media (EX-CELL, ISF-I, CD CHO, CDM4CHO, CHO-III-A, Octomed and HybridoMed) were evaluated and compared for cell growth and monoclonal antibody (mAb) production of a transfected CHO-K1 cell line. In the conditions assayed, EX-CELL and particularly CDM4CHO are the most recommended media for extended biopharmaceutical processes, on account of inducing superior levels of cell proliferation and mAb production, accentuated by a tendency to improve over time. Furthermore, the less positive results obtained with some media emphasize the importance and the impact of the correct medium selection.
机译:为使用哺乳动物细胞的特定生产过程选择无血清培养基是其成功的关键步骤。在这项研究中,评估了七种市售无血清培养基(EX-CELL,ISF-1,CD CHO,CDM4CHO,CHO-III-A,Octomed和HybridoMed),并比较了它们的细胞生长和单克隆抗体(mAb)产生转染的CHO-K1细胞系。在分析的条件下,EX-CELL,尤其是CDM4CHO,是诱导生物制药过程扩展的最推荐介质,因为它诱导了细胞增殖和mAb产生的高水平,并随着时间的流逝而逐渐改善。此外,某些媒体获得的不太积极的结果强调了正确选择媒体的重要性和影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号